Biolase, Inc. (BIOL): Price and Financial Metrics

Biolase, Inc. (BIOL): $0.84

0.09 (+11.90%)

POWR Rating

Component Grades














  • BIOL scores best on the Growth dimension, with a Growth rank ahead of 83.78% of US stocks.
  • BIOL's strongest trending metric is Growth; it's been moving down over the last 131 days.
  • BIOL's current lowest rank is in the Stability metric (where it is better than 3.07% of US stocks).

BIOL Stock Summary

  • With a market capitalization of $109,490,588, Biolase Inc has a greater market value than merely 15.7% of US stocks.
  • In terms of volatility of its share price, BIOL is more volatile than 95.36% of stocks we're observing.
  • Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for BIOL comes in at -34.64% -- higher than that of only 7.34% of stocks in our set.
  • If you're looking for stocks that are quantitatively similar to Biolase Inc, a group of peers worth examining would be KALA, QUOT, AAOI, TGA, and FOLD.
  • Visit BIOL's SEC page to see the company's official filings. To visit the company's web site, go to

BIOL Price Target

For more insight on analysts targets of BIOL, see our BIOL price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $2.00 Average Broker Recommendation 1.38 (Strong Buy)

BIOL Stock Price Chart Interactive Chart >

Price chart for BIOL

BIOL Price/Volume Stats

Current price $0.84 52-week high $1.51
Prev. close $0.75 52-week low $0.25
Day low $0.75 Volume 14,024,300
Day high $0.85 Avg. volume 19,638,402
50-day MA $0.74 Dividend yield N/A
200-day MA $0.62 Market Cap 125.63M

Biolase, Inc. (BIOL) Company Bio

BIOLASE, Inc.,a medical device company, develops, manufactures, and markets laser systems in dentistry and medicine in the United States and internationally. It offers Waterlase dental laser systems for cutting soft and hard tissue; and diode laser systems, which are used in soft tissue, pain therapy, and cosmetic procedures, such as teeth whitening. The company was founded in 1984 and is based in Irvine, California.

BIOL Latest News Stream

Event/Time News Detail
Loading, please wait...

BIOL Latest Social Stream

Loading social stream, please wait...

View Full BIOL Social Stream

Latest BIOL News From Around the Web

Below are the latest news stories about Biolase Inc that investors may wish to consider to help them evaluate BIOL as an investment opportunity.

Recent Studies Demonstrate BIOLASE's Waterlase Laser Technology is Beneficial for Treatment of Peri-Implantitis

BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that recent data published in two journals, the International Journal of Periodontics & Restorative Dentistry and Lasers in Medical Science, demonstrates BIOLASE's Waterlase Er,Cr:YSGG laser technology can be beneficial for the treatment of peri-implantitis in patients suffering from the inflammatory disease.

Yahoo | June 3, 2021

BIOLASE to Present at the Summer Solstice Best Ideas From the Buy Side Conference on June 2, 2021

FOOTHILL RANCH, Calif., June 1, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will be presenting at the Summer Solstice Best Ideas from the Buy Side Conference being held virtually on

Business Insider Markets | June 1, 2021

BIOLASE, Inc. (BIOL) CEO John Beaver on Q1 2021 Results - Earnings Call Transcript

BIOLASE, Inc. (BIOL) Q1 2021 Earnings Conference Call May 13, 2021 4:30 PM ET Company Participants Todd Kehrli - EVC Group John Beaver - President and Chief Executive Officer Jennifer Bright - Vice President, Finance Conference Call Participants Kyle Bauser - Colliers Securities Bruce Jackson - The Benchmark Company Ed...

SA Transcripts on Seeking Alpha | May 14, 2021

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on

We're getting you ready for the last day of trading this week with a look at the biggest pre-market stock movers for Friday!

William White on InvestorPlace | May 14, 2021

Biolase EPS misses by $0.01, beats on revenue; issues guidance

Biolase (BIOL): Q1 GAAP EPS of -$0.06 misses by $0.01.Revenue of $8.1M (+69.5% Y/Y) beats by $0.31M.Cash, cash equivalents, and restricted cash totaled $41.0M as of March 31, 2021.2021 Second Quarter Revenue Guidance : The Company continues to experience high demand for its dental lasers and is currently forecasting revenue...

Seeking Alpha | May 13, 2021

Read More 'BIOL' Stories Here

BIOL Price Returns

1-mo 44.83%
3-mo -14.17%
6-mo 185.71%
1-year 64.71%
3-year -32.26%
5-year -85.76%
YTD 101.58%
2020 -24.61%
2019 -44.17%
2018 -53.95%
2017 -69.29%
2016 66.67%

Continue Researching BIOL

Want to see what other sources are saying about Biolase Inc's financials and stock price? Try the links below:

Biolase Inc (BIOL) Stock Price | Nasdaq
Biolase Inc (BIOL) Stock Quote, History and News - Yahoo Finance
Biolase Inc (BIOL) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8339 seconds.